Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease.
Affiliation
Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland. cmgreene@rcsi.ieIssue Date
2010-01-01MeSH
AdolescentAdult
Aged
Autoantibodies
Autoimmune Diseases
Case-Control Studies
Cystic Fibrosis
Elastin
Female
Humans
Male
Middle Aged
Oligopeptides
Pulmonary Disease, Chronic Obstructive
Smoking
Young Adult
alpha 1-Antitrypsin Deficiency
Metadata
Show full item recordCitation
Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. 2010, 181 (1):31-5 Am. J. Respir. Crit. Care Med.Journal
American journal of respiratory and critical care medicineDOI
10.1164/rccm.200904-0545OCPubMed ID
19762563Additional Links
http://ajrccm.atsjournals.org/cgi/reprint/181/1/31Abstract
In patients with chronic inflammatory lung disease, pulmonary proteases can generate neoantigens from elastin and collagen with the potential to fuel autoreactive immune responses. Antielastin peptide antibodies have been implicated in the pathogenesis of tobacco-smoke-induced emphysema. Collagen-derived peptides may also play a role.To determine whether autoantibodies directed against elastin- and collagen-derived peptides are present in plasma from three groups of patients with chronic inflammatory lung disease compared with a nonsmoking healthy control group and to identify whether autoimmune responses to these peptides may be an important component of the disease process in these patients.
A total of 124 patients or healthy control subjects were recruited for the study (Z-A1AT deficiency, n = 20; cystic fibrosis, n = 40; chronic obstructive pulmonary disease, n = 31; healthy control, n = 33). C-reactive protein, IL-32, and antinuclear antibodies were quantified. Antielastin and anti-N-acetylated-proline-glycine-proline autoantibodies were measured by reverse ELISA.
All patients were deemed stable and noninfective on the basis of the absence of clinical or radiographic evidence of recent infection. There were no significant differences in the levels of autoantibodies or IL-32 in the patients groups compared with the healthy control subjects.
Antielastin or anti-N-acetylated proline-glycine-proline autoantibodies are not evident in chronic inflammatory lung disease.
Item Type
ArticleLanguage
enISSN
1535-4970ae974a485f413a2113503eed53cd6c53
10.1164/rccm.200904-0545OC
Scopus Count
Collections
Related articles
- Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
- Authors: Rinaldi M, Lehouck A, Heulens N, Lavend'homme R, Carlier V, Saint-Remy JM, Decramer M, Gayan-Ramirez G, Janssens W
- Issue date: 2012 Aug
- Smoke exposure as a determinant of autoantibody titre in α₁-antitrypsin deficiency and COPD.
- Authors: Wood AM, de Pablo P, Buckley CD, Ahmad A, Stockley RA
- Issue date: 2011 Jan
- Antielastin autoimmunity in tobacco smoking-induced emphysema.
- Authors: Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Cogswell S, Storness-Bliss C, Corry DB, Kheradmand F
- Issue date: 2007 May
- A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
- Authors: Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH
- Issue date: 1997 Mar-Apr
- Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease.
- Authors: Núñez B, Sauleda J, Antó JM, Julià MR, Orozco M, Monsó E, Noguera A, Gómez FP, Garcia-Aymerich J, Agustí A, PAC-COPD Investigators
- Issue date: 2011 Apr 15